

Author: Carpenter J.F. Prestrelski S.J. Dong A.
Publisher: Elsevier
ISSN: 0939-6411
Source: European Journal of Pharmaceutics and Biopharmaceutics, Vol.45, Iss.3, 1998-05, pp. : 231-238
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Development of Stable Lyophilized Protein Drug Products
Current Pharmaceutical Biotechnology, Vol. 13, Iss. 3, 2012-03 ,pp. :






By Gu Jian
Pharmaceutical Research, Vol. 30, Iss. 2, 2013-02 ,pp. :